Mrna Vaccines

What is CureVac's COVID-19 vaccine, and why it failed to cross 50% threshold in efficacy

Scientists have said the weaker-than-hoped results of the German vaccine may be down to the lower dosage, or even CureVac's recipe, which unlike its rivals uses an unmodified form of messenger RNA

Life-threatening allergic reaction to mRNA COVID-19 vaccination is rare, limited study suggests

People who got an anaphylactic episode following an mRNA vaccine dose usually had a history of allergy, or a previous instance of anaphylaxis.

Moderna's COVID-19 mRNA vaccine could revolutionise how pandemics are treated, but experts say to wait for Phase 3 human trials

The upcoming trials in 30,000 volunteers in a real-world setting will give experts a comprehensive look at its effectiveness and feasibility.